Ki-67 expression is a prognostic marker in many cancers, but it's also known as being heterogeneous. Taking this into account, can it serve as a prognostic marker for non-small cell lung cancer?

Natera has announced the initiation of the Phase II TEODOR trial of its Signatera test aimed at replacing chemotherapy with ...

Key Takeaways A high omega-3, low omega-6 diet with fish oil reduced the Ki-67 index by 15% in prostate cancer patients on active surveillance. The control group showed a 24% increase in the Ki-67 ...

The primary endpoint was the change in Ki-67 index from baseline to 1 year. During that time, the Ki-67 index decreased by 15% in the experimental arm and increased by 24% in the control arm (P ...

Mantle cell lymphoma treatment offers options if patients relapse after CAR T-cell therapy, from bispecific antibodies, antibody drug conjugates, and other emerging therapies.

NOTE. The lowest risk was estimated using age 75 years, grade 1, low Ki-67, smallest tumor size and lowest number of involved lymph nodes for the given stage group, and detection by screening. The ...

Key Takeaways A high omega-3, low omega-6 diet with fish oil reduced the prostate Ki-67 index by 15% in prostate cancer patients. The CAPFISH-3 trial involved 100 men on active surveillance for grade ...